Drug intelligence / Profile preview

VoWen T

Development stage: Unknown
Lead developer: Weber & Weber
Administration: Oral

Overview

VoWen T is a homeopathic complex medicinal product developed by Weber & Weber Biologische Arzneimittel. It is composed of a specific combination of snake venoms, typically including Vipera berus, Lachesis mutus, Crotalus horridus, and Naja tripudians in homeopathic dilutions. The product is indicated for the relief of symptoms associated with inflammatory and degenerative diseases of the musculoskeletal system, such as rheumatism, joint pain, and neuralgia. It is designed to stimulate the body's endogenous regulatory mechanisms to address inflammation and associated pain.

Brand names: VoWen T
Other names: VoWen-T

Beyond the preview

Go deeper on VoWen T.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VoWen T.

Explore the full profile